With Record-Setting Speed, Vaccinemakers Take Their First Shots at the New Coronavirus
Despite facing challenges, COVID-19 vaccine development continues to progress.
Despite facing challenges, COVID-19 vaccine development continues to progress.
In the world's second-largest country by population, the coronavirus poses a unique problem. A 21-day lockdown might help curb the virus' impact on the nation's 1.3 billion people.
Pet testing gains interest after three dogs tested positive for coronavirus.
The crowded race to develop a vaccine against the new coronavirus just received a potential billion-dollar boost.
A provocative, ethically complicated proposal to speed up coronavirus vaccine development is gaining traction.
Public health officials worldwide are watching closely as China addresses COVID-19.
In Iran, the fight against the coronavirus is complicated by two other battles: the weight of US-imposed sanctions and the spread of misinformation.
Health authorities in parts of Asia have encouraged all citizens to wear masks in public to prevent the spread of the virus.
George Gao oversees 2,000 employees as the director-general of the Chinese Center for Disease Control and Prevention.
More than 200 million pregnant women around the world are potentially at risk of infection with the new virus.
Researchers are now gearing up to scour the patients’ genomes for DNA variations that explain this mystery.
COVID-19 isn’t the first infectious disease scientists have modeled—Ebola and Zika are recent examples—but never has so much depended on their work.